3-Amino-1-phenyl-2-pyrazolin-5-oneCAS# 4149-06-8 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 4149-06-8 | SDF | Download SDF |
| PubChem ID | 77794 | Appearance | Powder |
| Formula | C9H9N3O | M.Wt | 175 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5-amino-2-phenyl-4H-pyrazol-3-one | ||
| SMILES | C1C(=NN(C1=O)C2=CC=CC=C2)N | ||
| Standard InChIKey | LPOVZHYARSAVIZ-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C9H9N3O/c10-8-6-9(13)12(11-8)7-4-2-1-3-5-7/h1-5H,6H2,(H2,10,11) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
3-Amino-1-phenyl-2-pyrazolin-5-one Dilution Calculator
3-Amino-1-phenyl-2-pyrazolin-5-one Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.7143 mL | 28.5714 mL | 57.1429 mL | 114.2857 mL | 142.8571 mL |
| 5 mM | 1.1429 mL | 5.7143 mL | 11.4286 mL | 22.8571 mL | 28.5714 mL |
| 10 mM | 0.5714 mL | 2.8571 mL | 5.7143 mL | 11.4286 mL | 14.2857 mL |
| 50 mM | 0.1143 mL | 0.5714 mL | 1.1429 mL | 2.2857 mL | 2.8571 mL |
| 100 mM | 0.0571 mL | 0.2857 mL | 0.5714 mL | 1.1429 mL | 1.4286 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Belinostat (PXD101)
Catalog No.:BCC2153
CAS No.:414864-00-9
- Turkesterone
Catalog No.:BCN2363
CAS No.:41451-87-0
- Bruceantin
Catalog No.:BCN7618
CAS No.:41451-75-6
- Onetine
Catalog No.:BCN2102
CAS No.:41451-67-6
- Phalaenopsine Is
Catalog No.:BCN2016
CAS No.:41451-64-3
- (+)-N-Methylallosedridine
Catalog No.:BCN5470
CAS No.:41447-16-9
- (-)-N-Methylsedridine
Catalog No.:BCN5469
CAS No.:41447-15-8
- ODQ
Catalog No.:BCC6829
CAS No.:41443-28-1
- 5-Heptadecylresorcinol
Catalog No.:BCN4750
CAS No.:41442-57-3
- 8-Hydroxyapigenin
Catalog No.:BCN8404
CAS No.:41440-05-5
- 5-Benzoylpentanoic acid
Catalog No.:BCC8740
CAS No.:4144-62-1
- Cirsilineol
Catalog No.:BCN2560
CAS No.:41365-32-6
- 12-Oleanene-3,6-diol
Catalog No.:BCN3903
CAS No.:41498-79-7
- Daturaolone
Catalog No.:BCN3904
CAS No.:41498-80-0
- Koaburaside monomethyl ether
Catalog No.:BCN5471
CAS No.:41514-64-1
- 2,6,16-Kauranetriol
Catalog No.:BCN5472
CAS No.:41530-90-9
- 1-(3,4-dimethoxyphenyl)-2-(4-allly-2,6-dimethoxyphenoxy)propan-1-ol
Catalog No.:BCN1445
CAS No.:41535-95-9
- N6-Cyclopentyladenosine
Catalog No.:BCC7160
CAS No.:41552-82-3
- SN-6
Catalog No.:BCC7273
CAS No.:415697-08-4
- RI-1
Catalog No.:BCC1896
CAS No.:415713-60-9
- Poricoic acid G
Catalog No.:BCN8267
CAS No.:415724-84-4
- Carboplatin
Catalog No.:BCC1170
CAS No.:41575-94-4
- 4,R-ajmalicine N-oxide
Catalog No.:BCN5473
CAS No.:41590-29-8
- (-)-Pinoresinol 4-O-glucoside
Catalog No.:BCN7251
CAS No.:41607-20-9
An efficient and green reaction of isatins, 3-amino-1-phenyl-2-pyrazolin-5-one (3-amine-1H-pyrazole), and beta-diketone in aqueous medium.[Pubmed:28828682]
Mol Divers. 2017 Nov;21(4):985-997.
An efficient and green reaction of isatins, 3-Amino-1-phenyl-2-pyrazolin-5-one (3-amine-1H-pyrazole), and [Formula: see text]-diketone in aqueous medium in the presence of [Formula: see text]-[Formula: see text] is reported, and a series of novel spirocompounds was obtained with high yields. The advantages of this reaction were simple procedure, moderate reaction conditions, and wide range of substrates. More importantly, the catalyst [Formula: see text]-[Formula: see text] could be recovered for reuse up to five times.
Aminoazoles in heterocyclic synthesis. Synthesis of some new pyrimidobenzimidazoles and pyrazolonopyridines as well as triazolo-, tetrazolo- and pyrazolo-pyrimidines of pharmaceutical interest.[Pubmed:8913052]
Boll Chim Farm. 1996 Apr;135(4):232-5.
The reactivity of 3-cinnamoylindole, 3-cinnamoylantipyrine and 1-(3-methyl-1-phenyl-5-pyrazolon-4 yl)-4-antipyrin-4-yl)-prop-2-ene-1- one(la-c) towards 2-aminobenzimidazole, 3-amino-1,2,4-triazole, 5-aminotetrazole monohydrate, 5-amino-3-phenylpyrazole and 3-Amino-1-phenyl-2-pyrazolin-5-one to give the fused heterocycles 2a-c, 4a,b, 5a,b, 8a,b, and 10a-c has been investigated. Structures of the synthesized compounds were confirmed by both the analytical and the spectral data (IR, UV and 1H NMR).
Quantitation of N-demethylantipyrine in biological samples and isolation and characterization of its glucuronic acid conjugate.[Pubmed:26550]
Drug Metab Dispos. 1978 May-Jun;6(3):288-95.
An improved method for quantitating N-demethylantipyrine (N-DEM-AP) in urine by gas chromatography or gas chromatography-mass spectrometry has been developed. Recovery of greater than 90% of N-DEM-AP was achieved by extraction of the sample at pH 1 after addition of 3-Amino-1-phenyl-2-pyrazolin-5-one. The coefficient of variation of replicate analyses was 8%. N-DEM-AP was excreted in the urine as a glucuronic acid conjugate. This conjugate was isolated from the urine of an individual receiving antipyrine and purified. The NMR and mass-spectral data are consistent with the conjugate being an O-glucuronide of N-DEM-AP in its enol form.
